Highlights
- AFFO and distributions: $555.0 million (51.6 cents per security), down 3.0% YoY
- Statutory net loss: $752.7 million; FY22 profit: $1,615.9 million due to fair valuation losses in FY23 vs gains in FY22
ROCE: 8.0%
- Pro forma Gearing: 27.9%; 86% of debt hedged with 4.8-year average maturity
- Completed acquisition of AMP Capital’s domestic real estate in March 2023
- Raised $1.6 billion of new equity across various platforms
- $1.8 billion in asset sales; strengthening balance sheet
- High occupancy: 95.9% for office, 99.4% for industrial
- Portfolio valuations led to 6.9% decrease on prior book values; NTA per security down 11.4% to $10.88
- Underlying Funds From Operations: $688.3 million, down 6.3% YoY
CFO Keir Barnes emphasised distribution in line with free cash flow and strong rent collections: 99.6% in FY23
- Forums
- ASX - By Stock
- DXS
- Ann: 2023 Annual Results Presentation
DXS
dexus
Add to My Watchlist
0.00%
!
$6.96

Ann: 2023 Annual Results Presentation, page-2
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
$6.96 |
Change
0.000(0.00%) |
Mkt cap ! $7.485B |
Open | High | Low | Value | Volume |
$6.97 | $6.99 | $6.93 | $11.43M | 1.643M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | $6.95 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$6.97 | 39577 | 2 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 1500 | 6.950 |
1 | 9650 | 6.940 |
5 | 4927 | 6.900 |
1 | 3700 | 6.870 |
1 | 159 | 6.850 |
Price($) | Vol. | No. |
---|---|---|
6.980 | 5000 | 1 |
7.000 | 2000 | 1 |
7.010 | 491 | 1 |
7.050 | 6000 | 2 |
7.100 | 1700 | 2 |
Last trade - 16.12pm 04/07/2025 (20 minute delay) ? |
Featured News
DXS (ASX) Chart |
The Watchlist
NUZ
NEURIZON THERAPEUTICS LIMITED
Dr Michael Thurn, CEO & MD
Dr Michael Thurn
CEO & MD
SPONSORED BY The Market Online